Is it time to replace the tuberculin skin test with a blood test?
- PMID: 22797639
- PMCID: PMC4629850
- DOI: 10.1001/jama.2012.7511
Is it time to replace the tuberculin skin test with a blood test?
Conflict of interest statement
Comment in
-
Interferon-γ-release assays for latent tuberculosis.JAMA. 2012 Nov 21;308(19):1971; author reply 1971. doi: 10.1001/jama.2012.12817. JAMA. 2012. PMID: 23168817 No abstract available.
Similar articles
-
[Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].Mikrobiyol Bul. 2007 Apr;41(2):193-202. Mikrobiyol Bul. 2007. PMID: 17682705 Turkish.
-
Profile of interferon-gamma response to latency-associated and novel in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis.Tuberculosis (Edinb). 2015 Dec;95(6):751-757. doi: 10.1016/j.tube.2015.08.002. Epub 2015 Sep 1. Tuberculosis (Edinb). 2015. PMID: 26421415
-
Differential positive TSPOT assay responses to ESAT-6 and CFP-10 in health care workers.Tuberculosis (Edinb). 2016 Dec;101S:S83-S91. doi: 10.1016/j.tube.2016.09.012. Epub 2016 Sep 28. Tuberculosis (Edinb). 2016. PMID: 27727133
-
Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis.Lancet Infect Dis. 2020 Dec;20(12):1457-1469. doi: 10.1016/S1473-3099(20)30276-0. Epub 2020 Jul 13. Lancet Infect Dis. 2020. PMID: 32673595
-
Interferon gamma release assays: principles and practice.Enferm Infecc Microbiol Clin. 2010 Apr;28(4):245-52. doi: 10.1016/j.eimc.2009.05.012. Epub 2009 Sep 24. Enferm Infecc Microbiol Clin. 2010. PMID: 19783328 Review.
Cited by
-
Pharmacist perceptions of the New Mexico pharmacist-performed tuberculosis testing program.J Am Pharm Assoc (2003). 2018 Nov-Dec;58(6):647-651. doi: 10.1016/j.japh.2018.08.010. Epub 2018 Sep 28. J Am Pharm Assoc (2003). 2018. PMID: 30274884 Free PMC article.
-
Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients.J Clin Microbiol. 2021 Sep 20;59(10):e0141421. doi: 10.1128/JCM.01414-21. Epub 2021 Aug 4. J Clin Microbiol. 2021. PMID: 34346720 Free PMC article.
-
High Immunogenicity of a T-Cell Epitope-Rich Recombinant Protein Rv1566c-444 From Mycobacterium tuberculosis in Immunized BALB/c Mice, Despite Its Low Diagnostic Sensitivity.Front Immunol. 2022 Feb 21;13:824415. doi: 10.3389/fimmu.2022.824415. eCollection 2022. Front Immunol. 2022. PMID: 35265079 Free PMC article.
-
Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection.PLoS One. 2015 Mar 18;10(3):e0120006. doi: 10.1371/journal.pone.0120006. eCollection 2015. PLoS One. 2015. PMID: 25785445 Free PMC article.
-
Cigarette-Smoking Intensity and Interferon-Gamma Release Assay Conversion among Persons Who Inject Drugs: A Cohort Study.Pulm Med. 2012;2012:828106. doi: 10.1155/2012/828106. Epub 2012 Dec 10. Pulm Med. 2012. PMID: 23304497 Free PMC article.
References
-
- Hill AN, Becerra JE, Castro KG. Modelling tuberculosis trends in the USA. Epidemiol Infect. 2012;11:1–11. - PubMed
-
- American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49(RR-6):1–51. - PubMed
-
- de Perio MA, Tsevat J, Roselle GA, Kralovic SM, Eckman MH. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. Arch Intern Med. 2009;169(2):179–187. - PubMed